Arkolith/Insider Trading/CDTX/Form 4

RA Capital Healthcare Fund LP

Director, 10% OwnerCidara Therapeutics, Inc. (CDTX) · full profile →Form 4 · filed Jan 9, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Option exercise(M)1.3M—$04.7M
Jan 7, 2026Disposed to issuer(D)4.7M$221.50$1.0B0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Option exercise(M)1.3M——0
Jan 7, 2026Disposed to issuer(D)5K——0
Jan 7, 2026Disposed to issuer(D)90K$15505.00$1.4B0
Jan 7, 2026Disposed to issuer(D)22K——0

Transaction Codes

M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000031) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML